Pfizer says its experimental antibiotic combo can treat some superbug infections
(VOVWORLD) - Pfizer said on Thursday data from late-stage trials showed its experimental combination of antibiotics was effective in treating deadly infections caused by drug-resistant bacteria.
 Company logo is seen at a Pfizer office in Puurs, Belgium. (Photo: REUTERS) |
Deaths from antibiotic-resistant bacteria, also known as superbugs, have been on the rise globally, and health regulators have called for the development of newer treatments as resistance to older antibiotics grows.
Pfizer said the data from the studies shows the antibiotic combination of ATM-AVI is effective and well-tolerated in treating infections caused by gram-negative bacteria.
The Centers for Disease Control and Prevention estimates that 2.8 million antimicrobial-resistant infections occur each year in the United States.